Executive Summary
Ultrahuman has closed a Series C funding round of approximately Rs 400 crore ($48 million) as it seeks to re-enter the US market with its redesigned Ring Pro smart ring. This follows a patent infringement ruling that barred its previous Ring Air model. Conflicting reports surround lead investor Premji Invest, with CEO Mohit Kumar denying involvement, a claim that media outlet YourStory could not independently confirm. The funding round underscores the challenges wearable tech companies face in navigating patent landscapes during global expansion.
Key Insights
The $48 million capital infusion is intended to support Ultrahuman's return to the US market, expand into new geographies, and develop new wearable categories, according to a senior company executive. The executive cited potential products in wristband form factors and new home lines. CEO Mohit Kumar declined to comment further on funding details.
Patent History and Redesign Imperative
In August, the US International Trade Commission ruled in favor of Oura in a patent dispute against Ultrahuman and China's RingConn, finding Ultrahuman in violation of design patents related to the ring's form factor. The commission issued exclusion orders banning imports and cease-and-desist orders blocking sales, effective October 21. According to an executive, the dispute centered on how the ring's battery was integrated within its casing. In response, Ultrahuman redesigned the Ring Pro from the ground up to avoid patent infringement, with a focus on longer battery life and greater computing power.
Product Differentiation and Market Positioning
Ultrahuman has positioned the Ring Pro as a performance-focused upgrade to the Ring Air, launched in 2022. CEO Mohit Kumar stated that the Pro offers 15 days of battery life for performance, while the Air prioritizes comfort with 5-6 day battery life and lightweight design. The Ring Pro is currently available in India, Europe, the UAE, and Australia, with plans for US re-entry after receiving official approval, as reported by The CapTable. In an internal message, Kumar described this as a major breakthrough for the company's US ambitions.
Funding Context and Investor Backing
To date, Ultrahuman has raised over $60 million in equity funding from investors including Rainmatter Capital, Nexus Venture Partners, Blume Ventures, Alpha Wave Incubation, and Steadview Capital, along with angels such as Deepinder Goyal. In November 2025, the company secured Rs 100 crore ($11 million) in venture debt from Alteria Capital. The Series C round comes as Ultrahuman prepares for its US re-entry, with executives indicating that more funding may follow in the coming months.
Strategic Implications
The Ultrahuman case highlights structural shifts in the wearable technology sector, affecting industry players and policymakers.
Industry Impact: Patent Wars Reshape Competitive Dynamics
Patent protection is becoming a core competitive element in the smart wearable market, forcing companies to balance innovation with legal risk management. The dispute with Oura shows how design patents can dictate market access, compelling redesigns and influencing R&D priorities.
Investor Perspective: High-Risk Capital in Regulated Environments
Investors backing Ultrahuman demonstrate appetite for high-stakes ventures, but face risks from legal uncertainties and market barriers. The conflicting investor reports add to this risk, though the funding enables critical re-entry efforts.
Competitive Landscape: Oura's Defensive Advantage and Market Barriers
Oura's patent win strengthens its market position, creating entry barriers. Ultrahuman's move to develop new categories like wristbands indicates a diversification strategy to mitigate future legal challenges, potentially leading to market fragmentation.
Policy Implications: ITC Rulings Set Global Precedents
The US International Trade Commission's ruling influences global tech competition by setting precedents for patent compliance. This could increase scrutiny in other regions, affecting international product launches and prompting calls for harmonized patent laws.
The Bottom Line
Ultrahuman's Series C funding is crucial for its global ambitions following a legal setback. Success depends on the Ring Pro's market acceptance and avoiding further patent disputes. For the wearable tech sector, this episode underscores that intellectual property is now as critical as technology, dictating market access and competitive viability.
Source: YourStory
Intelligence FAQ
The $48 million injection enables Ultrahuman to overcome patent barriers and re-enter the US market, signaling intensified competition and innovation within legal constraints.
Ultrahuman must ensure Ring Pro's redesign avoids infringement, execute a successful market re-entry, and manage investor uncertainty amid ongoing legal pressures.
The discrepancy introduces investor uncertainty, but the capital raise itself demonstrates strong backing for high-stakes tech ventures navigating regulated markets.
